|
1
|
Lin DC, Wang MR and Koeffler HP: Genomic
and epigenomic aberrations in esophageal squamous cell carcinoma
and implications for patients. Gastroenterology. 154:374–389. 2018.
View Article : Google Scholar :
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesopha-geal squamous cell cancer. Nature.
509:91–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steeg PS: Targeting metastasis. Nat Rev
Cancer. 16:201–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Joyce JA and Pollard JW:
Micro-environmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fife CM, McCarroll JA and Kavallaris M:
Movers and shakers: Cell cytoskeleton in cancer metastasis. Br J
Pharmacol. 171:5507–5523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McCubrey JA, Abrams SL, Fitzgerald TL,
Cocco L, Martelli AM, Montalto G, Cervello M, Scalisi A, Candido S,
Libra M and Steelman LS: Roles of signaling pathways in drug
resistance, cancer initiating cells and cancer progression and
metastasis. Adv Biol Regul. 57:75–101. 2015. View Article : Google Scholar
|
|
10
|
Bonapace L, Coissieux MM, Wyckoff J, Mertz
KD, Varga Z, Junt T and Bentires-Alj M: Cessation of CCL2
inhibition accelerates breast cancer metastasis by promoting
angiogenesis. Nature. 515:130–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Turajlic S and Swanton C: Metastasis as an
evolutionary process. Science. 352:169–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
White BD, Chien AJ and Dawson DW:
Dysregulation of Wnt/β-catenin signaling in gastrointestinal
cancers. Gastroenterology. 142:219–232. 2012. View Article : Google Scholar
|
|
14
|
Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang
S, Ding Y and Lin J: TUSC3 promotes colorectal cancer progression
and epithelial-mesenchymal transition (EMT) through WNT/β-catenin
and MAPK signalling. J Pathol. 239:60–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han B, Wang J, Gao J, Feng S, Zhu Y, Li X,
Xiao T, Qi J and Cui W: DJ-1 as a potential biomarker for the early
diagnosis in lung cancer patients. Tumour Biol.
39:10104283177146252017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawate T, Iwaya K, Koshikawa K, Moriya T,
Yamasaki T, Hasegawa S, Kaise H, Fujita T, Matsuo H, Nakamura T, et
al: High levels of DJ-1 protein and isoelectric point 63 isoform in
sera of breast cancer patients. Cancer Sci. 106:938–943. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Benati M, Montagnana M, Danese E, Paviati
E, Giudici S, Ruzzenente O, Franchi M and Lippi G: The clinical
significance of DJ-1 and HE4 in patients with endometrial cancer. J
Clin Lab Anal. 32:2018. View Article : Google Scholar
|
|
18
|
Chan JY and Chan SH: Activation of
endogenous antioxidants as a common therapeutic strategy against
cancer, neurodegeneration and cardiovascular diseases: A lesson
learnt from DJ-1. Pharmacol Ther. 156:69–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuen HF, Chan YP, Law S, Srivastava G,
El-Tanani M, Mak TW and Chan KW: DJ-1 could predict worse prognosis
in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers
Prev. 17:3593–3602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jue C, Lin C, Zhisheng Z, Yayun Q, Feng J,
Min Z, Haibo W, Youyang S, Hisamitsu T, Shintaro I, et al: Notch1
promotes vasculogenic mimicry in hepatocellular carcinoma by
inducing EMT signaling. Oncotarget. 8:2501–2513. 2017. View Article : Google Scholar :
|
|
21
|
Da C, Liu Y, Zhan Y, Liu K and Wang R:
Nobiletin inhibits epithelial-mesenchymal transition of human
non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3
signaling pathway. Oncol Rep. 35:2767–2774. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Geng XF, Fang M, Liu SP and Li Y: Quantum
dot-based molecular imaging of cancer cell growth using a clone
formation assay. Mol Med Rep. 14:3007–3012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao J, Yang W, Xu B, Zhu H, Zou J, Su C,
Rong J, Wang T and Chen Z: Expression of fibronectin in esophageal
squamous cell carcinoma and its role in migration. BMC Cancer.
18:9762018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu Y, Liu Y, Qian Y, Dai X, Yang L, Chen
J, Guo S and Hisamitsu T: Research on the efficacy of Celastrus
Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal
transition by inhibiting HSP27 and TNF-α-induced NF-κB/Snail
signaling pathway in human gastric adenocarcinoma. BMC Complement
Altern Med. 14:4332014. View Article : Google Scholar
|
|
25
|
Aleyasin H, Rousseaux MW, Marcogliese PC,
Hewitt SJ, Irrcher I, Joselin AP, Parsanejad M, Kim RH, Rizzu P,
Callaghan SM, et al: DJ-1 protects the nigrostriatal axis from the
neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad
Sci USA. 107:3186–3191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim RH, Peters M, Jang Y, Shi W, Pintilie
M, Fletcher GC, DeLuca C, Liepa J, Zhou L, Snow B, et al: DJ-1, a
novel regulator of the tumor suppressor PTEN. Cancer Cell.
7:263–273. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clements CM, McNally RS, Conti BJ, Mak TW
and Ting JP: DJ-1, a cancer- and Pa2rkinson's disease-associated
protein, stabilizes the antioxidant transcriptional master
regulator Nrf2. Proc Natl Acad Sci USA. 103:15091–15096. 2006.
View Article : Google Scholar
|
|
28
|
Hurst DR and Welch DR: Metastasis
suppressor genes at the interface between the environment and tumor
cell growth. Int Rev Cell Mol Biol. 286:107–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou J, Liu H, Zhang L, Liu X, Zhang C,
Wang Y, He Q, Zhang Y, Li Y, Chen Q, et al: DJ-1 promotes
colorectal cancer progression through activating PLAGL2/Wnt/BMP4
axis. Cell Death Dis. 9:8652018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie
H, Zhou L, Wu J and Zheng S: MiR-126-3p suppresses tumor metastasis
and angiogenesis of hepatocellular carcinoma by targeting LRP6 and
PIK3R2. J Transl Med. 12:2592014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tung EK, Wong BY, Yau TO and Ng IO:
Upregulation of the Wnt Co-receptor LRP6 promotes
hepatocarcinogenesis and enhances cell invasion. PLoS One.
7:e365652012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamamoto H, Komekado H and Kikuchi A:
Caveolin is necessary for Wnt-3a-dependent internalization of LRP6
and accumulation of beta-catenin. Dev Cell. 11:213–223. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tang X, Fan Z, Wang Y, Ji G, Wang M, Lin J
and Huang S: Expression of klotho and β-catenin in esophageal
squamous cell carcinoma, and their clinicopathological and
prognostic signifi-cance. Dis Esophagus. 29:207–214. 2016.
View Article : Google Scholar
|
|
38
|
Chiurillo MA: Role of the Wnt/β-catenin
pathway in gastric cancer: An in-depth literature review. World J
Exp Med. 5:84–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
To SKY, Mak ASC, Eva Fung YM, Che CM, Li
SS, Deng W, Ru B, Zhang J and Wong AST: β-catenin downregulates
Dicer to promote ovarian cancer metastasis. Oncogene. 36:5927–5938.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu X, Luo F, Li J, Zhong X and Liu K:
Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon
cancer cell lines via inhibition of the Wnt signaling pathway. Int
J Oncol. 48:1333–1340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo W, Shen F, Xiao W, Chen J and Pan F:
Wnt inhibitor XAV939 suppresses the viability of small cell lung
cancer NCI-H446 cells and induces apoptosis. Oncol Lett.
14:6585–6591. 2017.
|
